TAMARA JARROUS: Open Payments
NPI 1366969230 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 31 payments from 8 companies in 2025. Trend: 2023 $3,452 · 2024 $2,814 · 2025 $608
Food & beverage: $608
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 10 | $183 |
| Neurocrine BioSciences, Inc. | 6 | $131 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $127 |
| Lundbeck LLC | 3 | $66 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Alkermes, Inc. | 1 | $16 |
Products named: SPRAVATO, INGREZZA, CAPLYTA, REXULTI, INVEGA SUSTENNA, Auvelity, FANAPT, ARISTADA.
Industry payments across TX — which companies pay providers there.
